Position in NVCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,359,991
+$1,752,902 QoQ
Shares Held
216,513
+361.1% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 86.69963663726101.ToString("F0")%
Shared 0.07376164592429778.ToString("F0")%
None 13.226601716814685.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Corient Private Wealth LLC holds $730,623,455 across 43 Medical Devices names. NVCR ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
1,098,311 | $360,894,011 | |
| 2 | ABT |
Abbott Laboratories
|
1,667,187 | $171,170,088 | |
| 3 | MASI |
Masimo Corp
|
321,600 | $57,202,992 | |
| 4 | MDT |
Medtronic plc
|
560,236 | $48,544,449 | |
| 5 | GMED |
Globus Medical Inc
|
184,510 | $15,897,381 | |
| 6 | PODD |
Insulet Corp
|
67,983 | $14,265,552 | |
| 7 | BSX |
Boston Scientific Corp
|
186,603 | $11,709,337 | |
| 8 | DXCM |
Dexcom Inc
|
126,752 | $7,960,025 |
All Filings in NVCR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,359,991 | 216,513 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $607,089 | 46,952 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $452,548 | 35,027 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $329,940 | 18,536 | Shares | Sole | 2025-09-26 | |
| 2025-03-31 | $212,842 | 11,944 | Shares | Sole | 2025-05-14 | |
| 2023-03-31 | $296,610 | 4,932 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $221,517 | 3,020 | Shares | Sole | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||